Cargando…
Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis
Gastroparesis is a very common condition, however many times it becomes difficult to manage even after long-term treatment due to multiple etiologies or improper therapy. Patients with severe gastroparesis are considered candidates for gastric electrical stimulants. The “Pulse Therapy” using metoclo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649867/ https://www.ncbi.nlm.nih.gov/pubmed/26664852 http://dx.doi.org/10.4103/2249-4863.123944 |
_version_ | 1782401434102267904 |
---|---|
author | Shah, Shamik Kaswala, Dharmesh Patel, Nishith Sood, Sunita Brelvi, Zamir |
author_facet | Shah, Shamik Kaswala, Dharmesh Patel, Nishith Sood, Sunita Brelvi, Zamir |
author_sort | Shah, Shamik |
collection | PubMed |
description | Gastroparesis is a very common condition, however many times it becomes difficult to manage even after long-term treatment due to multiple etiologies or improper therapy. Patients with severe gastroparesis are considered candidates for gastric electrical stimulants. The “Pulse Therapy” using metoclopramide and erythromycin to reprogram gastric motility can delay or even avoid the need for gastric electrical stimulants. This case report focuses on a patient with severe gastroparesis, who was considered for a gastric pacemaker implantation and was instead treated successfully with “Pulse Therapy.” As a part of this regimen, he was given metoclopramide continuously for 3 months along with pulses of erythromycin for 10 days a month for 3 months. Patient recovered dramatically that he no longer remained a candidate for gastric pacemaker implantation. This case study emphasizes on how the proper use of prokinetic agents based on symptoms and gastric emptying study can reprogram the stomach motility in these patients with severe gastroparesis. |
format | Online Article Text |
id | pubmed-4649867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-46498672015-12-10 Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis Shah, Shamik Kaswala, Dharmesh Patel, Nishith Sood, Sunita Brelvi, Zamir J Family Med Prim Care Case Report Gastroparesis is a very common condition, however many times it becomes difficult to manage even after long-term treatment due to multiple etiologies or improper therapy. Patients with severe gastroparesis are considered candidates for gastric electrical stimulants. The “Pulse Therapy” using metoclopramide and erythromycin to reprogram gastric motility can delay or even avoid the need for gastric electrical stimulants. This case report focuses on a patient with severe gastroparesis, who was considered for a gastric pacemaker implantation and was instead treated successfully with “Pulse Therapy.” As a part of this regimen, he was given metoclopramide continuously for 3 months along with pulses of erythromycin for 10 days a month for 3 months. Patient recovered dramatically that he no longer remained a candidate for gastric pacemaker implantation. This case study emphasizes on how the proper use of prokinetic agents based on symptoms and gastric emptying study can reprogram the stomach motility in these patients with severe gastroparesis. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC4649867/ /pubmed/26664852 http://dx.doi.org/10.4103/2249-4863.123944 Text en Copyright: © Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Shah, Shamik Kaswala, Dharmesh Patel, Nishith Sood, Sunita Brelvi, Zamir Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis |
title | Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis |
title_full | Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis |
title_fullStr | Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis |
title_full_unstemmed | Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis |
title_short | Reprogramming of Gastric Motility with “Pulse Therapy” (Metoclopramide and Erythromycin) in Severe Gastroparesis |
title_sort | reprogramming of gastric motility with “pulse therapy” (metoclopramide and erythromycin) in severe gastroparesis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649867/ https://www.ncbi.nlm.nih.gov/pubmed/26664852 http://dx.doi.org/10.4103/2249-4863.123944 |
work_keys_str_mv | AT shahshamik reprogrammingofgastricmotilitywithpulsetherapymetoclopramideanderythromycininseveregastroparesis AT kaswaladharmesh reprogrammingofgastricmotilitywithpulsetherapymetoclopramideanderythromycininseveregastroparesis AT patelnishith reprogrammingofgastricmotilitywithpulsetherapymetoclopramideanderythromycininseveregastroparesis AT soodsunita reprogrammingofgastricmotilitywithpulsetherapymetoclopramideanderythromycininseveregastroparesis AT brelvizamir reprogrammingofgastricmotilitywithpulsetherapymetoclopramideanderythromycininseveregastroparesis |